Radiotherapy in management of pancreatic cancer: application and prospect

Abstract

CLC Number:

R735.9

WU Lili, XU Yaolin, LOU Wenhui. Radiotherapy in management of pancreatic cancer: application and prospect[J]. Journal of Surgery Concepts & Practice, 2022, 27(01): 25-29.

References37

[1]	Cai J, Chen H, Lu M, et al. Advances in the epidemiology of pancreatic cancer: Trends, risk factors, screening, and prognosis[J]. Cancer Letters, 2021, 520:1-11. doi:10.1016/j.canlet.2021.06.027 URL
[2]	Kalser MH, Ellenberg SS. Pancreatic cancer. adjuvant combined radiation and chemotherapy following curative resection[J]. Arch Surg, 1985, 120(8):899-903. doi:10.1001/archsurg.1985.01390320023003 URL
[3]	Gastrointestinal Tumor Study Group. Further evidence of effective adjuvant combined radiation and chemotherapy following curative resection of pancreatic cancer[J]. Cancer, 1987, 59(12):2006-2010. doi:10.1002/1097-0142(19870615)59:12<2006::AID-CNCR2820591206>3.0.CO;2-B URL
[4]	Smeenk HG, van Eijck CH, Hop WC, et al. Long-term survival and metastatic pattern of pancreatic and periampullary cancer after adjuvant chemoradiation or observation: long-term results of EORTC trial 40891[J]. Ann Surg, 2007, 246(5):734-740. pmid:17968163
[5]	Klinkenbijl JH, Jeekel J, Sahmoud T, et al. Adjuvant radiotherapy and 5-fluorouracil after curative resection of cancer of the pancreas and periampullary region: phase Ⅲ trial of the EORTC gastrointestinal tract cancer co-operative group[J]. Ann Surg, 1999, 230(6):776-782. pmid:10615932
[6]	Regine WF, Winter KA, Abrams R, et al. Fluorouracil-based chemoradiation with either gemcitabine or fluorouracil chemotherapy after resection of pancreatic adenocarcinoma: 5-year analysis of the U.S. Intergroup/RTOG 9704 phase Ⅲ trial[J]. Ann Surg Oncol, 2011, 18(5):1319-1326. doi:10.1245/s10434-011-1630-6 URL
[7]	Regine WF, Winter KA, Abrams RA, et al. Fluorouracilvs. gemcitabine chemotherapy before and after fluorouracil-based chemoradiation following resection of pancreatic adenocarcinoma: a randomized controlled trial[J]. JAMA, 2008, 299(9):1019-1026. doi:10.1001/jama.299.9.1019 URL
[8]	Rutter CE, Park HS, Corso CD, et al. Addition of radiotherapy to adjuvant chemotherapy is associated with improved overall survival in resected pancreatic adenocarcinoma: an analysis of the national cancer data base[J]. Cancer, 2015, 121(23):4141-4149. doi:10.1002/cncr.29652 URL
[9]	Hsu CC, Herman JM, Corsini MM, et al. Adjuvant chemoradiation for pancreatic adenocarcinoma: the Johns Hopkins Hospital-Mayo Clinic collaborative study[J]. Ann Surg Oncol, 2010, 17(4):981-990. doi:10.1245/s10434-009-0743-7 URL
[10]	Neoptolemos JP, Stocken DD, Friess H, et al. A rando-mized trial of chemoradiotherapy and chemotherapy after resection of pancreatic cancer[J]. N Engl J Med, 2004, 350(12):1200-1210. doi:10.1056/NEJMoa032295 URL
[11]	Neoptolemos JP, Dunn JA, Stocken DD, et al. Adjuvant chemoradiotherapy and chemotherapy in resectable pancreatic cancer: a randomised controlled trial[J]. Lancet, 2001, 358(9293):1576-1585. pmid:11716884
[12]	van Laethem JL, Hammel P, Mornex F, et al. Adjuvant gemcitabine alone versus gemcitabine-based chemoradiotherapy after curative resection for pancreatic cancer: a randomized EORTC-40013-22012/FFCD-9203/GERCOR phase Ⅱ study[J]. J Clin Oncol, 2010, 28(29):4450-4456. doi:10.1200/JCO.2010.30.3446 URL
[13]	Naffouje SA, Sabesan A, Kim DW, et al. Adjuvant chemoradiotherapy in resected pancreatic ductal adenocarcinoma: where does the benefit lie? a nomogram for risk stratification and patient selection[J]. J Gastrointest Surg, 2021-09-10[online ahead of print].
[14]	Abrams RA, Winter KA, Regine WF, et al. Failure to adhere to protocol specified radiation therapy guidelines was associated with decreased survival in RTOG 9704--a phaseⅢ trial of adjuvant chemotherapy and chemoradiotherapy for patients with resected adenocarcinoma of the pancreas[J]. Int J Radiat Oncol Biol Phys, 2012, 82(2):809-816. doi:10.1016/j.ijrobp.2010.11.039 URL
[15]	中华医学会外科学分会胰腺外科学组. 中国胰腺癌诊治指南(2021)[J]. 中华外科杂志, 2021, 59(7):561-577.
[16]	Palta M, Godfrey D, Goodman KA, et al. Radiation therapy for pancreatic cancer: executive summary of an ASTRO Clinical Practice Guideline[J]. Pract Radiat On-col, 2019, 9(5):322-332.
[17]	Khorana AA, Mangu PB, Berlin J, et al. Potentially cu-rable pancreatic cancer: American Society of Clinical Oncology Clinical Practice Guideline[J]. J Clin Oncol, 2016, 34(21):2541-2556. doi:10.1200/JCO.2016.67.5553pmid:27247221
[18]	Tempero MA, Malafa MP, Al-Hawary M, et al. Pancreatic adenocarcinoma, version 2.2021, NCCN clinical practice guidelines in oncology[J]. J Natl Compr Canc Netw, 2021, 19(4):439-457. doi:10.6004/jnccn.2021.0017 URL
[19]	Cohen SJ, Dobelbower RJ, Lipsitz S, et al. A randomized phaseⅢ study of radiotherapy alone or with 5-fluorouracil and mitomycin-C in patients with locally advanced adenocarcinoma of the pancreas: Eastern Co-operative Oncology Group study E8282[J]. Int J Radiat On-col Biol Phys, 2005, 62(5):1345-1350.
[20]	The Gastrointestinal Tumor Study Group. A multi-institutional comparative trial of radiation therapy alone and in combination with 5-fluorouracil for locally unresectable pancreatic carcinoma[J]. Ann Surg, 1979, 189(2):205-208.
[21]	Sultana A, Tudur SC, Cunningham D, et al. Systematic review, including meta-analyses, on the management of locally advanced pancreatic cancer using radiation/combined modality therapy[J]. Br J Cancer, 2007, 96(8):1183-1190. doi:10.1038/sj.bjc.6603719 URL
[22]	Huguet F, Girard N, Guerche CS, et al. Chemoradiothe-rapy in the management of locally advanced pancreatic carcinoma: a qualitative systematic review[J]. J Clin Oncol, 2009, 27(13):2269-2277. doi:10.1200/JCO.2008.19.7921 URL
[23]	Wu L, Zhou Y, Fan Y, et al. Consolidative chemoradiotherapy after induced chemotherapy is an optimal regimen for locally advanced pancreatic cancer[J]. Front Oncol, 2019, 9:1543. doi:10.3389/fonc.2019.01543 URL
[24]	Schneider BJ, Ben-Josef E, McGinn CJ, et al. Capecitabine and radiation therapy preceded and followed by combination chemotherapy in advanced pancreatic cancer[J]. Int J Radiat Oncol Biol Phys, 2005, 63(5):1325-1330. doi:10.1016/j.ijrobp.2005.04.030 URL
[25]	Lawrence TS, Eisbruch A, Shewach DS. Gemcitabine-mediated radiosensitization[J]. Semin Oncol, 1997, 24(2 Suppl 7):S7-S24. pmid:9194476
[26]	Blackstock AW, Tepper JE, Niedwiecki D, et al. Cancer and leukemia group B (CALGB) 89805: phase Ⅱ chemoradiation trial using gemcitabine in patients with locoregional adenocarcinoma of the pancreas[J]. Int J Gastrointest Cancer, 2003, 34(2-3):107-116. pmid:15361643
[27]	Cardenes HR, Moore AM, Johnson CS, et al. A phase Ⅱ study of gemcitabine in combination with radiation therapy in patients with localized, unresectable, pancreatic cancer: a Hoosier Oncology Group study[J]. Am J Clin Oncol, 2011, 34(5):460-465. doi:10.1097/COC.0b013e3181e9c103 URL
[28]	Li CP, Chao Y, Chi KH, et al. Concurrent chemoradiotherapy treatment of locally advanced pancreatic cancer: gemcitabine versus 5-fluorouracil, a randomized controlled study[J]. Int J Radiat Oncol Biol Phys, 2003, 57(1):98-104. doi:10.1016/S0360-3016(03)00435-8 URL
[29]	Brasiuniene B, Juozaityte E. The effect of combined treatment methods on survival and toxicity in patients with pancreatic cancer[J]. Medicina (Kaunas), 2007, 43(9):716-725.
[30]	Hurt CN, Falk S, Crosby T, et al. Long-term results and recurrence patterns from SCALOP: a phaseⅡ randomised trial of gemcitabine- or capecitabine-based chemoradiation for locally advanced pancreatic cancer[J]. Br J Cancer, 2017, 116(10):1264-1270. doi:10.1038/bjc.2017.95 URL
[31]	Mahadevan A, Miksad R, Goldstein M, et al. Induction gemcitabine and stereotactic body radiotherapy for locally advanced nonmetastatic pancreas cancer[J]. Int J Radiat Oncol Biol Phys, 2011, 81(4):e615-e622. doi:10.1016/j.ijrobp.2011.04.045 URL
[32]	Huguet F, Andre T, Hammel P, et al. Impact of chemoradiotherapy after disease control with chemotherapy in locally advanced pancreatic adenocarcinoma in GERCOR phase Ⅱ and Ⅲ studies[J]. J Clin Oncol, 2007, 25(3):326-331. doi:10.1200/JCO.2006.07.5663 URL
[33]	Hammel P, Huguet F, van Laethem JL, et al. Effect of chemoradiotherapyvs. chemotherapy on survival in patients with locally advanced pancreatic cancer controlled after 4 months of gemcitabine with or without erlotinib: the LAP07 randomized clinical trial[J]. JAMA, 2016, 315(17):1844-1853. doi:10.1001/jama.2016.4324 URL
[34]	Perri G, Prakash L, Qiao W, et al. Response and survival associated with first-line FOLFIRINOXvs. gemcitabine and nab-paclitaxel chemotherapy for localized pancreatic ductal adenocarcinoma[J]. JAMA Surg, 2020, 155(9):832-839. doi:10.1001/jamasurg.2020.2286 URL
[35]	Gemenetzis G, Groot VP, Blair AB, et al. Survival in locally advanced pancreatic cancer after neoadjuvant the-rapy and surgical resection[J]. Ann Surg, 2019, 270(2):340-347. doi:10.1097/SLA.0000000000002753pmid:29596120
[36]	Hayashi T, Nakamura T, Kimura Y, et al. Phase 2 study of neoadjuvant treatment of sequential S-1-based concurrent chemoradiation therapy followed by systemic chemotherapy with gemcitabine for borderline resectable pancreatic adenocarcinoma(HOPS-BR 01)[J]. Int J Radiat Oncol Biol Phys, 2019, 105(3):606-617. doi:10.1016/j.ijrobp.2019.07.004 URL
[37]	Li Y, Feng Q, Jin J, et al. Experts′ consensus on intra-operative radiotherapy for pancreatic cancer[J]. Cancer Lett, 2019, 449:1-7. doi:10.1016/j.canlet.2019.01.038 URL

Radiotherapy in management of pancreatic cancer: application and prospect

RichHTML

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References37

Related Articles15

Recommended Articles

Metrics

Comments

[1]	ZHANG Hongzhan, ZHANG Kai.Current status and prospect of endoscopic photodynamic therapy for unresectable extrahepatic cholangiocarcinoma and ampullary carcinoma[J]. Journal of Surgery Concepts & Practice, 2023, 28(04): 316-320.
[2]	GAO Pan, CAI Yunqiang, PENG Bing.Function-preserving laparoscopic resection of pancreatic head and duodenal papilla tumors[J]. Journal of Surgery Concepts & Practice, 2023, 28(03): 190-196.
[3]	YU Lan, ZHANG Yongyi, HUANG Lei, WAN Xin, JIANG Shengyao, TANG Sijing, ZHANG Jun, HU Weiguo.Risk factors of severe postoperative complications in elderly patients with pancreaticoduodenectomy[J]. Journal of Surgery Concepts & Practice, 2023, 28(02): 139-146.
[4]	XIE Xuehai, YANG Yinmo.Evaluation and technical key points of pancreaticojejunostomy[J]. Journal of Surgery Concepts & Practice, 2022, 27(01): 1-5.
[5]	HE Min, LIU Yingbin.Resectable pancreatic cancer: diagnosis criterion, treatment and controversy[J]. Journal of Surgery Concepts & Practice, 2022, 27(01): 6-10.
[6]	SHI Yihua, JI Shunrong, XU Xiaowu, YU Xianjun.Minimally invasive enucleation of pancreatic tumor: technical note and thinking[J]. Journal of Surgery Concepts & Practice, 2022, 27(01): 14-18.
[7]	LI Ji, FU Deliang, NI Quanxing.Surgical decision making for pancreatic cystic neoplasm: selection of local enucleation[J]. Journal of Surgery Concepts & Practice, 2022, 27(01): 19-21.
[8]	WANG Chong, CHENG Shi.Consensus and controversy: preoperative biliary drainage for resectable pancreatic cancer[J]. Journal of Surgery Concepts & Practice, 2022, 27(01): 30-33.
[9]	WANG Wei, HUA Jie.Common vascular variations and coping strategies in pancreaticoduodenectomy[J]. Journal of Surgery Concepts & Practice, 2022, 27(01): 34-38.
[10]	WEI Jishu, HUANG Shimeng.Perineural invasion and neural plasticity in pancreatic cancer: study history and current treatment[J]. Journal of Surgery Concepts & Practice, 2022, 27(01): 42-45.
[11]	YANG Chunxue, XU Haimin, DA Qian.Clinicopathological features of pancreatic intraductal oncocytic papillary neoplasm: a report of 5 cases[J]. Journal of Surgery Concepts & Practice, 2022, 27(01): 52-57.
[12]	XU Yu, ZHANG Junfeng, HUA Rong.Use of octreotide for prevention of pancreatic leak after pancreatoduodenectomy: study progress[J]. Journal of Surgery Concepts & Practice, 2022, 27(01): 83-86.
[13]	LUO Danyang, GAO Yiming.Study on oral microflora related to pancreatic cancer[J]. Journal of Surgery Concepts & Practice, 2021, 26(01): 84-86.
[14]	DING Fangmi, LIU Zhendong.Forkhead box D1 promotes invasion and metastasis of pancreatic cancer via extracellular signal-regulated kinase pathway[J]. Journal of Surgery Concepts & Practice, 2020, 25(06): 486-492.
[15]	QIAN Lihan, SHN Baiyong.Research progress on comprehensive treatment of locally advanced pancreatic cancer[J]. Journal of Surgery Concepts & Practice, 2020, 25(05): 442-446.